Earnings Feed
Start Free
Home/Insiders/Odence-Ford Marion
OM
SEC Insider//CIK 0001845002

Odence-Ford Marion

CIK 00018450021 companyWALTHAM, MA
SEC Profile

Transactions

50

Companies

1

Filings

8

CIK

0001845002

Recent Transactions

50 trades
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-12-19$13.51/sh−1,153→ 93,373 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-12-19+3,928→ 94,526 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-12-19−3,928→ 3,928 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-10-03+6,649→ 92,550 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-10-03$18.75/sh−1,952→ 90,598 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-10-03−6,649→ 0 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2025-08-21+35,156→ 35,156 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2025-08-21+15,625→ 85,901 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-03-01−771→ 0 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-03-01+771→ 70,544 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-03-01$5.18/sh−268→ 70,276 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-02-15$6.64/sh−1,479→ 69,773 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2025-02-11$5.60/sh−1,386→ 71,252 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2025-02-11+4,000→ 72,638 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2025-02-11−4,000→ 12,000 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2024-12-23+77,742→ 77,742 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2024-12-23+41,408→ 68,638 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-12-20$4.75/sh−1,153→ 27,230 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-12-19−3,927→ 7,856 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-12-19+3,927→ 28,383 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-11-08+1,785→ 24,980 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-11-08−1,785→ 0 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-11-08$6.27/sh−524→ 24,456 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-10-03$7.83/sh−1,952→ 23,195 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-10-03+6,649→ 25,147 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-10-03−6,649→ 6,649 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-03-01−771→ 771 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-01$15.95/sh−268→ 14,231 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-03-01+771→ 14,499 total
  • Award
    OptimizeRx Corp$OPRX

    Common Stock

    2024-02-15+4,267→ 18,498 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2024-02-11+4,000→ 15,114 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2024-02-11$15.39/sh−1,386→ 13,728 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2024-02-11−4,000→ 16,000 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2024-01-09$15.19/sh−4,000→ 11,114 total
  • Award
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-12-19+11,783→ 11,783 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2023-12-19+11,783→ 11,783 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2023-11-08$9.21/sh−524→ 15,114 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-11-08−1,785→ 1,785 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2023-11-08+1,785→ 15,638 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-10-03−6,649→ 13,298 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2023-10-03+6,649→ 15,805 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2023-10-03$7.06/sh−1,952→ 13,853 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2023-03-01$18.11/sh−268→ 9,156 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-03-01−771→ 1,542 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2023-03-01+771→ 9,424 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2023-02-11−4,000→ 12,000 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2023-02-11$17.34/sh−1,422→ 8,653 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2023-02-11+4,000→ 10,075 total
  • Tax Payment
    OptimizeRx Corp$OPRX

    Common Stock

    2022-11-08$14.52/sh−710→ 6,075 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Restricted Stock Units

    2022-11-08−1,785→ 3,570 total

Companies

1

Recent Filings

8

Address

C/O OPTIMIZERX CORPORATION 260 CHARLES STREET, SUITE 302

WALTHAM, MA, 02453

View on SEC.gov